Calendar · pharmadog

Sign In Subscribe

Week of Oct 20, 2025

50

Oct 21, 2025approval312d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

Sponsor: HIKMA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗

Oct 21, 2025approval312d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

Sponsor: STRIDES PHARMA INTL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →tramadol hydrochloride ER →fda approvals ↗

Oct 21, 2025approval312d agoSPEVIGO (SPESOLIMAB-SBZO) — FDA approvalspesolimab

Sponsor: BOEHRINGER INGELHEIM PHARMACEUTICALS INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →spesolimab →fda approvals ↗

Oct 21, 2025approval312d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 21, 2025approval312d agoBLINCYTO (BLINATUMOMAB) — FDA approvalblinatumomab

Sponsor: AMGEN. Form: INJECTABLE. Route: INJECTION

full page →blinatumomab →fda approvals ↗

Oct 21, 2025approval312d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

Sponsor: PHARMACYCLICS LLC. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

Oct 21, 2025approval312d agoCELECOXIB — FDA approvalCelebrex

Sponsor: LUPIN LTD. Form: CAPSULE. Route: ORAL

full page →Celebrex →fda approvals ↗

Oct 21, 2025approval312d agoTRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalChartwell Pharmaceuticals LLC

Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 21, 2025approval312d agoTRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalChartwell Pharmaceuticals LLC

Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 21, 2025approval312d agoCALCIUM CHLORIDE 10% (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →CALCIUM CHLORIDE 10% →fda approvals ↗

Oct 21, 2025approval312d agoMIEBO (PERFLUOROHEXYLOCTANE) — FDA approvalBausch & Lomb Corp

Sponsor: BAUSCH AND LOMB INC. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Oct 21, 2025approval312d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

Sponsor: PHARMACYCLICS LLC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 21, 2025approval312d agoSUMATRIPTAN SUCCINATE — FDA approvalTonix Pharmaceuticals Holding Corp.

Sponsor: PH HEALTH. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →fda approvals ↗

Oct 21, 2025approval312d agoSTIMUFEND (PEGFILGRASTIM-FPGK) — FDA approvalSTIMUFEND

Sponsor: FRESENIUS KABI USA. Form: SOLUTION. Route: INJECTION

full page →STIMUFEND →fda approvals ↗

Oct 21, 2025approval312d agoDEFERASIROX — FDA approvalDEFERASIROX

Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →DEFERASIROX →fda approvals ↗

Oct 21, 2025approval312d agoDEFERASIROX — FDA approvalDEFERASIROX

Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →DEFERASIROX →fda approvals ↗

Oct 21, 2025approval312d agoDEFERASIROX — FDA approvalDEFERASIROX

Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →DEFERASIROX →fda approvals ↗

Oct 21, 2025approval312d agoDEFERASIROX — FDA approvalDEFERASIROX

Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →DEFERASIROX →fda approvals ↗

Oct 21, 2025approval312d agoDEFERASIROX — FDA approvalDEFERASIROX

Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →DEFERASIROX →fda approvals ↗

Oct 21, 2025approval312d agoDEFERASIROX — FDA approvalDEFERASIROX

Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →DEFERASIROX →fda approvals ↗

Oct 22, 2025approval311d agoSIMPONI (GOLIMUMAB) — FDA approvalJanssen Biotech Inc

Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Oct 22, 2025approval311d agoNICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE (NICARDIPINE HYDROCHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: CAPLIN. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Oct 22, 2025approval311d agoESMOLOL HYDROCHLORIDE — FDA approvalESMOLOL HYDROCHLORIDE

Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

full page →ESMOLOL HYDROCHLORIDE →fda approvals ↗

Oct 22, 2025approval311d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: L PERRIGO CO. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Oct 22, 2025approval311d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: L PERRIGO CO. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Oct 22, 2025approval311d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: L PERRIGO CO. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Oct 22, 2025approval311d agoOXALIPLATIN — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Oct 22, 2025approval311d agoCONTEPO (FOSFOMYCIN DISODIUM) — FDA approvalfosfomycin disodium

Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

full page →fosfomycin disodium →fda approvals ↗

Oct 22, 2025approval311d agoVYEPTI (EPTINEZUMAB-JJMR) — FDA approvalH. Lundbeck AS

Sponsor: Lundbeck Seattle BioPharmaceuticals, Inc.. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Oct 22, 2025approval311d agoVISINE (NAPHAZOLINE HYDROCHLORIDE) — FDA approval

Sponsor: KENVUE BRANDS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Oct 22, 2025approval311d agoLOFEXIDINE HYDROCHLORIDE — FDA approvalLOFEXIDINE HYDROCHLORIDE

Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

full page →LOFEXIDINE HYDROCHLORIDE →fda approvals ↗

Oct 22, 2025approval311d agoARIPIPRAZOLE — FDA approvalaripiprazole LA

Sponsor: QUAGEN. Form: SOLUTION. Route: ORAL

full page →aripiprazole LA →fda approvals ↗

Oct 23, 2025approval310d agoVORICONAZOLE — FDA approvalVORICONAZOLE

Sponsor: CADILA. Form: TABLET. Route: ORAL

full page →VORICONAZOLE →fda approvals ↗

Oct 23, 2025approval310d agoOMVOH (MIRIKIZUMAB-MRKZ) — FDA approvalmirikizumab

Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →mirikizumab →fda approvals ↗

Oct 23, 2025approval310d agoJAVADIN (CLONIDINE HYDROCHLORIDE) — FDA approvalclonidine hydrochloride

Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

full page →clonidine hydrochloride →fda approvals ↗

Oct 23, 2025approval310d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Oct 23, 2025approval310d agoDALBAVANCIN HYDROCHLORIDE — FDA approvalFresenius Kabi USA LLC

Sponsor: TEVA PHARMS INC. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Oct 23, 2025approval310d agoVORICONAZOLE — FDA approvalMylan Pharmaceuticals Inc

Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 23, 2025approval310d agoBLENREP (BELANTAMAB MAFODOTIN-BLMF) — FDA approvalbelantamab mafodotin

Sponsor: GLAXOSMITHKLINE LLC. Form: INJECTABLE. Route: INJECTION

full page →belantamab mafodotin →fda approvals ↗

Oct 23, 2025approval310d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: RISING. Form: INJECTABLE. Route: INJECTION

full page →ondansetron hydrochloride CR →fda approvals ↗

Oct 23, 2025approval310d agoDEHYDRATED ALCOHOL — FDA approval

Sponsor: ROYAL PHARMS. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Oct 23, 2025approval310d agoDESIPRAMINE HYDROCHLORIDE — FDA approvalDESIPRAMINE HYDROCHLORIDE

Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL

full page →DESIPRAMINE HYDROCHLORIDE →fda approvals ↗

Oct 23, 2025approval310d agoDOCOSANOL — FDA approvalPL Developments Copiague LLC

Sponsor: DR REDDYS. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Oct 23, 2025approval310d agoQUINAPRIL HYDROCHLORIDE — FDA approvalLupin Ltd

Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 23, 2025approval310d agoQUINAPRIL HYDROCHLORIDE — FDA approvalLupin Ltd

Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 23, 2025approval310d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Oct 23, 2025approval310d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Oct 23, 2025approval310d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

Sponsor: ACTAVIS LABS FL. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Oct 23, 2025approval310d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

Sponsor: ACTAVIS LABS FL. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Oct 24, 2025approval309d agoNEFFY (EPINEPHRINE) — FDA approvalInternational Medication Systems Ltd

Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL

full page →fda approvals ↗

page 337 of 380